Skip to content

MAZE MAZE Earnings yield

Earnings yield at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
3.8%
Septerna, Inc. logo
Septerna, Inc.SEPN
-3.3%-1.6pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-8.8%-22.8pp
Zymeworks logo
ZymeworksZYME
-5.5%-2.1pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-18%+0.2pp
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-23.1%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Calculated from MAZE’s reported figures.

Based on trailing twelve months.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's earnings yield?
MAZE (MAZE) reported earnings yield of -8.3% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.